Central effects of fexofenadine and cetirizine: Measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography

Manabu Tashiro, Yumiko Sakurada, Kentaro Iwabuchi, Hideki Mochizuki, Motohisa Kato, Mariko Aoki, Yoshihito Funaki, Masatoshi Itoh, Ren Iwata, Dean Foster Wong, Kazuhiko Yanai

Research output: Contribution to journalArticle

Abstract

Histamine H1-receptor (H1R) antagonists, or antihistamines, often induce sedative side effects when used for the treatment of allergic disorders. This study compared the sedative profiles of the second-generation antihistamines, fexofenadine and cetirizine, using 3 different criteria: subjective sleepiness evaluated by the Stanford Sleepiness Scale, objective psychomotor tests (simple and choice reaction time tests and visual discrimination tests at 4 different exposure durations), and measurement of histamine H1-receptor occupancy (H1RO) in the brain. Subjective sleepiness and psychomotor performance were measured in 20 healthy Japanese volunteers at baseline and 90 min after administration of fexofenadine 120 mg or cetirizine 20 mg in a double-blind, placebo-controlled crossover study. Hydroxyzine 30 mg was included as a positive control. H1RO was measured using positron emission tomography (PET) with 11C-doxepin in 12 of the 20 subjects, and a further 11 volunteers were recruited to act as controls. In psychomotor tests, fexofenadine was not significantly different from placebo and significantly less impairing than cetirizine on some tasks, as well as significantly less impairing than hydroxyzine on all tasks. For subjective sleepiness, fexofenadine was not significantly different from placebo, whereas cetirizine showed a trend toward increased sleepiness compared with fexofenadine and placebo. H1RO was negligible with fexofenadine (-0.1%) but moderately high with cetirizine (26.0%). In conclusion, fexofenadine 120 mg is distinguishable from cetirizine 20 mg, as assessed by H1RO and psychomotor testing.

Original languageEnglish (US)
Pages (from-to)890-900
Number of pages11
JournalJournal of Clinical Pharmacology
Volume44
Issue number8
DOIs
StatePublished - Aug 2004

Fingerprint

fexofenadine
Doxepin
Cetirizine
Psychomotor Performance
Histamine H1 Receptors
Positron-Emission Tomography
Brain
Placebos
Hydroxyzine
Hypnotics and Sedatives
Non-Sedating Histamine H1 Antagonists
Histamine H1 Antagonists
Histamine Antagonists
Cross-Over Studies
Reaction Time
Volunteers

Keywords

  • Cetirizine
  • Fexofenadine
  • H1-receptor occupancy (H1RO)
  • Histamine H1-receptor (H1R)
  • Positron emission tomography (PET)
  • Psychomotor performance
  • Second-generation antihistamine
  • Sleepiness

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Central effects of fexofenadine and cetirizine : Measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography. / Tashiro, Manabu; Sakurada, Yumiko; Iwabuchi, Kentaro; Mochizuki, Hideki; Kato, Motohisa; Aoki, Mariko; Funaki, Yoshihito; Itoh, Masatoshi; Iwata, Ren; Wong, Dean Foster; Yanai, Kazuhiko.

In: Journal of Clinical Pharmacology, Vol. 44, No. 8, 08.2004, p. 890-900.

Research output: Contribution to journalArticle

Tashiro, Manabu ; Sakurada, Yumiko ; Iwabuchi, Kentaro ; Mochizuki, Hideki ; Kato, Motohisa ; Aoki, Mariko ; Funaki, Yoshihito ; Itoh, Masatoshi ; Iwata, Ren ; Wong, Dean Foster ; Yanai, Kazuhiko. / Central effects of fexofenadine and cetirizine : Measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography. In: Journal of Clinical Pharmacology. 2004 ; Vol. 44, No. 8. pp. 890-900.
@article{25d21478d4c24796b8cb780c3705e9d1,
title = "Central effects of fexofenadine and cetirizine: Measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography",
abstract = "Histamine H1-receptor (H1R) antagonists, or antihistamines, often induce sedative side effects when used for the treatment of allergic disorders. This study compared the sedative profiles of the second-generation antihistamines, fexofenadine and cetirizine, using 3 different criteria: subjective sleepiness evaluated by the Stanford Sleepiness Scale, objective psychomotor tests (simple and choice reaction time tests and visual discrimination tests at 4 different exposure durations), and measurement of histamine H1-receptor occupancy (H1RO) in the brain. Subjective sleepiness and psychomotor performance were measured in 20 healthy Japanese volunteers at baseline and 90 min after administration of fexofenadine 120 mg or cetirizine 20 mg in a double-blind, placebo-controlled crossover study. Hydroxyzine 30 mg was included as a positive control. H1RO was measured using positron emission tomography (PET) with 11C-doxepin in 12 of the 20 subjects, and a further 11 volunteers were recruited to act as controls. In psychomotor tests, fexofenadine was not significantly different from placebo and significantly less impairing than cetirizine on some tasks, as well as significantly less impairing than hydroxyzine on all tasks. For subjective sleepiness, fexofenadine was not significantly different from placebo, whereas cetirizine showed a trend toward increased sleepiness compared with fexofenadine and placebo. H1RO was negligible with fexofenadine (-0.1{\%}) but moderately high with cetirizine (26.0{\%}). In conclusion, fexofenadine 120 mg is distinguishable from cetirizine 20 mg, as assessed by H1RO and psychomotor testing.",
keywords = "Cetirizine, Fexofenadine, H1-receptor occupancy (H1RO), Histamine H1-receptor (H1R), Positron emission tomography (PET), Psychomotor performance, Second-generation antihistamine, Sleepiness",
author = "Manabu Tashiro and Yumiko Sakurada and Kentaro Iwabuchi and Hideki Mochizuki and Motohisa Kato and Mariko Aoki and Yoshihito Funaki and Masatoshi Itoh and Ren Iwata and Wong, {Dean Foster} and Kazuhiko Yanai",
year = "2004",
month = "8",
doi = "10.1177/0091270004267590",
language = "English (US)",
volume = "44",
pages = "890--900",
journal = "Journal of Clinical Pharmacology",
issn = "0091-2700",
publisher = "SAGE Publications Inc.",
number = "8",

}

TY - JOUR

T1 - Central effects of fexofenadine and cetirizine

T2 - Measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography

AU - Tashiro, Manabu

AU - Sakurada, Yumiko

AU - Iwabuchi, Kentaro

AU - Mochizuki, Hideki

AU - Kato, Motohisa

AU - Aoki, Mariko

AU - Funaki, Yoshihito

AU - Itoh, Masatoshi

AU - Iwata, Ren

AU - Wong, Dean Foster

AU - Yanai, Kazuhiko

PY - 2004/8

Y1 - 2004/8

N2 - Histamine H1-receptor (H1R) antagonists, or antihistamines, often induce sedative side effects when used for the treatment of allergic disorders. This study compared the sedative profiles of the second-generation antihistamines, fexofenadine and cetirizine, using 3 different criteria: subjective sleepiness evaluated by the Stanford Sleepiness Scale, objective psychomotor tests (simple and choice reaction time tests and visual discrimination tests at 4 different exposure durations), and measurement of histamine H1-receptor occupancy (H1RO) in the brain. Subjective sleepiness and psychomotor performance were measured in 20 healthy Japanese volunteers at baseline and 90 min after administration of fexofenadine 120 mg or cetirizine 20 mg in a double-blind, placebo-controlled crossover study. Hydroxyzine 30 mg was included as a positive control. H1RO was measured using positron emission tomography (PET) with 11C-doxepin in 12 of the 20 subjects, and a further 11 volunteers were recruited to act as controls. In psychomotor tests, fexofenadine was not significantly different from placebo and significantly less impairing than cetirizine on some tasks, as well as significantly less impairing than hydroxyzine on all tasks. For subjective sleepiness, fexofenadine was not significantly different from placebo, whereas cetirizine showed a trend toward increased sleepiness compared with fexofenadine and placebo. H1RO was negligible with fexofenadine (-0.1%) but moderately high with cetirizine (26.0%). In conclusion, fexofenadine 120 mg is distinguishable from cetirizine 20 mg, as assessed by H1RO and psychomotor testing.

AB - Histamine H1-receptor (H1R) antagonists, or antihistamines, often induce sedative side effects when used for the treatment of allergic disorders. This study compared the sedative profiles of the second-generation antihistamines, fexofenadine and cetirizine, using 3 different criteria: subjective sleepiness evaluated by the Stanford Sleepiness Scale, objective psychomotor tests (simple and choice reaction time tests and visual discrimination tests at 4 different exposure durations), and measurement of histamine H1-receptor occupancy (H1RO) in the brain. Subjective sleepiness and psychomotor performance were measured in 20 healthy Japanese volunteers at baseline and 90 min after administration of fexofenadine 120 mg or cetirizine 20 mg in a double-blind, placebo-controlled crossover study. Hydroxyzine 30 mg was included as a positive control. H1RO was measured using positron emission tomography (PET) with 11C-doxepin in 12 of the 20 subjects, and a further 11 volunteers were recruited to act as controls. In psychomotor tests, fexofenadine was not significantly different from placebo and significantly less impairing than cetirizine on some tasks, as well as significantly less impairing than hydroxyzine on all tasks. For subjective sleepiness, fexofenadine was not significantly different from placebo, whereas cetirizine showed a trend toward increased sleepiness compared with fexofenadine and placebo. H1RO was negligible with fexofenadine (-0.1%) but moderately high with cetirizine (26.0%). In conclusion, fexofenadine 120 mg is distinguishable from cetirizine 20 mg, as assessed by H1RO and psychomotor testing.

KW - Cetirizine

KW - Fexofenadine

KW - H1-receptor occupancy (H1RO)

KW - Histamine H1-receptor (H1R)

KW - Positron emission tomography (PET)

KW - Psychomotor performance

KW - Second-generation antihistamine

KW - Sleepiness

UR - http://www.scopus.com/inward/record.url?scp=3242751214&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3242751214&partnerID=8YFLogxK

U2 - 10.1177/0091270004267590

DO - 10.1177/0091270004267590

M3 - Article

C2 - 15286093

AN - SCOPUS:3242751214

VL - 44

SP - 890

EP - 900

JO - Journal of Clinical Pharmacology

JF - Journal of Clinical Pharmacology

SN - 0091-2700

IS - 8

ER -